Skip to nav Skip to content
Claudia  Berman

Claudia Berman, MD

Specialty: Radiology

Program: Diagnostic Imaging and Interventional Radiology

Language(s): English

  • Overview

    Dr Berman has been with Moffitt since 1988 having completed residency training in Diagnostic Imaging and Fellowship training in Nuclear Medicine and Magnetic Resonance Imaging.

    Education & Training

    Fellowship:

    • University of South Florida - Magnetic Resonance Imaging
    • University of Pennsylvania - Nuclear Medicine

    Residency:

    • Mercy Catholic Medical Center, Philadelphia - Diagnostic Imaging

    Medical School:

    • Jefferson Medical College, PA - MD
  • Publications

    • Jeong D, Gage KL, Berman CG, Montilla-Soler JL. Cardiac Magnetic Resonance for Evaluating Catheter Related FDG Avidity. Case Rep Radiol. 2016 Nov.2016:5460727. Pubmedid: 27867676. Pmcid: PMC5102723.
    • Pimiento JM, Davis-Yadley AH, Kim RD, Chen DT, Eikman EA, Berman CG, Malafa MP. Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer. Clin Nucl Med. 2016 Mar.41(3):177-181. Pubmedid: 26673243. Pmcid: PMC4740191.
    • Hassani J, Porubsky C, Berman C, Zager J, Messina J, Henderson-Jackson E. Intraperitoneal Rosai-Dorfman disease associated with clear cell sarcoma: first case report. Pathology. 2016 Dec.48(7):742-744. Pubmedid: 27814905.
    • Jadvar H, Subramaniam R, Berman CG, Boada F, Colletti PM, Guimaraes A, McConathy J, Meltzer C, Noto RB, Packard A, Rohren E, Oates ME. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain. J Nucl Med. 2015 Apr.56(4):642-645. Pubmedid: 25745088. Pmcid: PMC4465538.
    • Kumar V, Nath K, Berman CG, Kim J, Tanvetyanon T, Chiappori AA, Gatenby RA, Gillies RJ, Eikman EA. Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med. 2013 Mar.38(3):175-182. Pubmedid: 23354032. Pmcid: PMC3578161.
    • Finkelstein SE, Iclozan C, Bui MM, Cotter MJ, Ramakrishnan R, Ahmed J, Noyes DR, Cheong D, Gonzalez RJ, Heysek RV, Berman C, Lenox BC, Janssen W, Zager JS, Sondak VK, Letson GD, Antonia SJ, Gabrilovich DI. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int J Radiat Oncol Biol Phys. 2012 Feb.82(2):924-932. Pubmedid: 21398051. Pmcid: PMC4241354.
    • Zager JS, Brodsky S, Berman CG. Imaging of Merkel cell carcinoma. Curr Prob Cancer. 2010 Jan.34(1):65-76. Pubmedid: 20371075.
    • Berman CG. Recent advances in breast-specific imaging. Cancer Control. 2007 Oct.14(4):338-349. Pubmedid: 17914334.
    • Li L, Wu Z, Salem A, Chen Z, Chen L, George F, Kallergi M, Berman C. Computerized analysis of tissue density effect on missed cancer detection in digital mammography. Comput Med Imag Grap. 2006 Jul.30(5):291-297. Pubmedid: 16837164.
    • Kallergi M, Lucier B, Berman C, Hersh M, Kim J, Szabunio M, Clark R. High-performance wavelet compression for mammography: localization response operating characteristic evaluation. Radiology. 2006 Jan.238(1):62-73. Pubmedid: 16373759.
    • Kallergi M, Berman C, Cressman J, Loeffler W, Pat Romilly A, Szabunio M, Vedam P, Venugopal P, Walker J. Clinical evaluation of a new digitizing device for improved film mammography. Acad Radiol. 2004 Nov.11(11):1242-1250. Pubmedid: 15561571.
    • Kallergi M, Heine J, Berman C, Hersh M, Romilly A, Clark R. Improved interpretation of digitized mammography with wavelet processing: a localization response operating characteristic study. Ajr Am J Roentgenol. 2004 Mar.182(3):697-703. Pubmedid: 14975972.
    • Cox C, Furman B, Stowell N, Ebert M, Clark J, Dupont E, Shons A, Berman C, Beauchamp J, Gardner M, Hersch M, Venugopal P, Szabunio M, Cressman J, Diaz N, Vrcel V, Fairclough R. Radioactive seed localization breast biopsy and lumpectomy: can specimen radiographs be eliminated?. Ann Surg Oncol. 2003 Nov.10(9):1039-1047. Pubmedid: 14597442.
    • Malhotra P, Berman CG. Evaluation of bone metastases in lung cancer. Improved sensitivity and specificity of PET over bone scanning. Cancer Control. 2002 May.9(3):254, 259-254, 260. Pubmedid: 12060823.
    • Goscin C, Berman C, Clark R. Magnetic resonance imaging of the breast. Cancer Control. 2001 Sep.8(5):399-406. Pubmedid: 11579335.
    • Gray R, Salud C, Nguyen K, Dauway E, Friedland J, Berman C, Peltz E, Whitehead G, Cox C. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001 Oct.8(9):711-715. Pubmedid: 11597011.
    • Dupont E, Kamath V, Ramnath E, Shivers S, Cox C, Berman C, Leight G, Ross J, Blumencranz P, Reintgen DS. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol. 2001 May.8(4):354-360. Pubmedid: 11352310.
    • Kamath V, Giuliano R, Dauway E, Cantor A, Berman C, Ku N, Cox C, Reintgen D. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001 Jun.136(6):688-692. Pubmedid: 11387010.
    • Bass SS, Cox CE, Salud CJ, Lyman G, McCann C, Dupont E, Berman C, Reintgen D. The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg. 2001 Jan.192(1):9-16. Pubmedid: 11192930.
    • Chirikos T, Berman C, Luther S, Clark R. Cost consequences of sentinel lymph node biopsy in the treatment of breast cancer. A preliminary analysis. Int J Technol Assess. 2001 Dec.17(4):626-631. Pubmedid: 11758307.
    • Cox C, Bass S, McCann C, Ku N, Berman C, Durand K, Bolano M, Wang J, Peltz E, Cox S, Salud C, Reintgen D, Lyman G. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med. 2000 May.51:525-542. Pubmedid: 10774480.
    • Berman C, Clark R. Positron emission tomography in initial staging and diagnosis of persistent or recurrent disease. Curr Opin Oncol. 2000 Mar.12(2):132-137. Pubmedid: 10750724.
    • Berman C, Choi J, Hersh M, Clark R. Melanoma lymphoscintigraphy and lymphatic mapping. Semin Nucl Med. 2000 Jan.30(1):49-55. Pubmedid: 10656243.
    • Smith D, Messina J, Perrott R, Berman C, Reintgen D, Cruse C, Glass F, DeConti R, Trotti A, Fenske N. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000 Jan.7(1):72-83. Pubmedid: 10740663.
    • Bass S, Dauway E, Mahatme A, Ku N, Berman C, Reintgen D, Cox C. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers <1 centimeter (t1a-t1b). am surg. 1999 sep.65(9):857-861. pubmedid:>10484089.
    • Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol. 1999 Sep.6(6):553-561. Pubmedid: 10493623.
    • Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, Cruse CW, Berman CG, Reintgen DS. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol. 1999 Mar.6(2):144-149. Pubmedid: 10082038.
    • Messina J, Glass L, Cruse C, Berman C, Ku N, Reintgen D. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol. 1999 Jun.23(6):686-690. Pubmedid: 10366151.
    • Kamath D, Milotes G, Lyman G, Rapaport D, Cruse C, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol. 1999 Jun.6(4):345-349. Pubmedid: 10379854.
    • Pendas S, Dauway E, Cox C, Giuliano R, Ku N, Schreiber R, Berman C, Reintgen D. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999 Jun.65(6):500-505. Pubmedid: 10366202.
    • Berman CG. Radiation safety and nuclear medicine policies and procedures. Surg Oncol Clin N Am. 1999 Jul.8(3):577-81, xi. Pubmedid: 10448699.
    • Brobeil A, Cruse CW, Messina JL, Glass LF, Haddad FF, Berman CG, Marshburn J, Reintgen DS. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am. 1999 Jul.8(3):435-45, viii. Pubmedid: 10448688.
    • Berman CG, Goscin C, Kim JJ, Miller MS. Lymphoscintigraphy in malignant melanoma and breast cancer. Surg Oncol Clin N Am. 1999 Jul.8(3):401-12, vii. Pubmedid: 10448685.
    • Dauway E, Giuliano R, Haddad F, Pendas S, Costello D, Cox C, Berman C, Ku N. Lymphatic mapping in breast cancer. Hematol Oncol Clin North Am. 1999 Apr.13(2):349-71, vi. Pubmedid: 10363135.
    • Dauway EL, Giuliano R, Pendas S, Haddad F, Costello D, Cox CE, Berman C, Ku NN, Reintgen DS. Lymphatic Mapping: A Technique Providing Accurate Staging for Breast Cancer. Breast Cancer. 1999 Apr.6(2):145-154. Pubmedid: 11091708.
    • Bass S, Dauway E, Mahatme A, Ku N, Berman C, Reintgen D, Cox C. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers < 1centimeter (T1A-T1B). Am Surg. 1999.65(9):857-862.
    • Cox C, Huddad F, Bass S, Cox J, Ku N, Berman C, Shons A, Pendas S, Reintgen D, Yeatman T. Lymphatic mapping in the treatment of breast cancer. Oncology (Williston Park). 1998 Sep.12(9):1283-1292. Pubmedid: 9778675.
    • Berman CG, Brodsky NJ. Newer Imaging Modalities. Cancer Control. 1998 Oct.5(5):450-464. Pubmedid: 10761095.
    • Kallergi M, Gavrielides M, He L, Berman C, Kim J, Clark R. Simulation model of mammographic calcifications based on the American College of Radiology Breast Imaging Reporting and Data System, or BIRADS. Acad Radiol. 1998 Oct.5(10):670-679. Pubmedid: 9787837.
    • Shivers S, Wang X, Li W, Joseph E, Messina J, Glass L, DeConti R, Cruse W, Berman C, Fenske N, Lyman G, Reintgen D. Molecular staging of malignant melanoma: correlation with clinical outcome. Jama. 1998 Oct.280(16):1410-1415. Pubmedid: 9801000.
    • Berman CG, Brodsky NJ. Prostate Cancer Imaging. Cancer Control. 1998 Nov.5(6):541-554. Pubmedid: 10761103.
    • Berman CG. Thallium Imaging of the Brain. Cancer Control. 1998 May.5(3):249-255. Pubmedid: 10761059.
    • Cox C, Pendas S, Cox J, Joseph E, Shons A, Yeatman T, Ku N, Lyman G, Berman C, Haddad F, Reintgen D. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998 May.227(5):645-651. Pubmedid: 9605656. Pmcid: PMC1191339.
    • Joseph E, Glass F, Glass J, Messina J, DeConti R, Cruse C, Rapaport D, Berman C, Fenske N, Reintgen D. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998 Mar.5(2):119-125. Pubmedid: 9527264.
    • Berman CB. Peripherally Enhancing Liver Mass. Cancer Control. 1998 Mar.5(2):171-175. Pubmedid: 10761028.
    • Brobeil A, Berman C, Cruse C, DeConti R, Cantor A, Lyman G, Rapaport D, Joseph E, Wells K, Reintgen D. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol. 1998 Jun.5(4):376-383. Pubmedid: 9641461.
    • Venugopal P, Berman C, Robinson L. The Pleural Tent. Cancer Control. 1998 Jan.5(1):41. Pubmedid: 10761016.
    • Reintgen D, Haddad F, Pendas S, Berman C, Ku N, Glass F, Messina J, Cox C. Sentinel node biopsy in ductal carcinoma in situ patients. Scientific America Surgery. 1998.12(9):1283-1292.
    • Reintgen D, Cox C, Haddad F, Costello D, Berman C. The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer. J Nucl Med. 1998.39(12):22N-36N. Pubmedid: 9867132.
    • Wells K, Rapaport D, Cruse C, Payne W, Albertini J, Berman C, Lyman G, Reintgen D. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997 Sep.100(3):591-594. Pubmedid: 9283554.
    • Berman CG. Gallium Scanning as a Prognostic Indicator in Lymphoma. Cancer Control. 1997 Oct.4(5):429. Pubmedid: 10763051.
    • Berman CG. Breast Lymphoscintigraphy. Cancer Control. 1997 Nov.4(6):523-527. Pubmedid: 10763061.
    • Ramnath E, Kamath D, Brobeil A, Stall A, Kamath V, Cruse C, Glass F, Messina J, Fenske N, Berman C, Cantor A, Cuthbertson D, Reintgen D, Ross M. Lymphatic Mapping for Melanoma: Long-term Results of Regional Nodal Sampling With Radioguided Surgery. Cancer Control. 1997 Nov.4(6):483-490. Pubmedid: 10763056.
    • Reintgen D, Joseph E, Lyman G, Yeatman T, Balducci L, Ku N, Berman C, Shons A, Wells K, Horton J, Greenberg H, Nicosia S, Clark R, Shivers S, Li W, Wang X, Cantor A, Cox C. The Role of Selective Lymphadenectomy in Breast Cancer. Cancer Control. 1997 May.4(3):211-219. Pubmedid: 10763020.
    • Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse C, Rapaport D, Berman C, Glass L, Fenske N, Einstein, Jr. A, Lyman G. Investment in new technology research can save future health care dollars. J Fla Med Assoc. 1997 Mar.84(3):175-181. Pubmedid: 9143169.
    • Brobeil A, Kamath D, Cruse CW, Rapaport DP, Wells KE, Shons AR, Messina JL, Glass LF, Berman CG, Puleo CA, Reintgen DS. The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc. 1997 Mar.84(3):157-160. Pubmedid: 9143166.
    • Kamath D, Rapaport D, DeConti R, Cruse C, Wells K, Glass L, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997 Mar.84(3):182-187. Pubmedid: 9143170.
    • Messina J, Reintgen D, Cruse C, Rapaport D, Berman C, Fenske N, Glass L. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997 Jul.4(5):389-395. Pubmedid: 9259965.
    • Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen D. Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol. 1997 Jan.4(1):19-23. Pubmedid: 8985513.
    • Schreiber R, Pendas S, Ku N, Reintgen D, Shons A, Berman C, Boulware D, Cox C. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol. 1997 Jan.6(1):95-101. Pubmedid: 10030421.
    • Cox CE, Hyacinthe M, Berman C, Dupont EL, Wagner A. Localization of an Occult Primary Breast Cancer with Technetium-99m Sestamibi Scan and an Intraoperative Gamma Probe. Cancer Control. 1996 Oct.3(5):448-450. Pubmedid: 10764504.
    • Berman C. Role of Percutaneous Biopsy and Aspiration in Patients With Cystic Renal Masses. Cancer Control. 1996 Nov.3(6):524. Pubmedid: 10764512.
    • Brobeil A, Berman C, Clark R, Cox C, Reintgen D. Medical-legal pitfalls for the breast surgeon: incomplete mammographic localization of suspicious lesions and the correlation between palpable and mammographic abnormalities. Am Surg. 1996 Jun.62(6):484-487. Pubmedid: 8651534.
    • Meliotis G, Albertini J, Berman C, Heller R, Messina J, Glass L, Cruse C, Rapaport D, Puleo C, Fenske N, Petsofglov C, DeConti R, Lyman G. The tumor biology of melanoma nodal metastases. Am Surg. 1996 Jan.62(1):81-88. Pubmedid: 8540654.
    • Berman C, Choi J. Radioimmunodetection of Colorectal Carcinoma. Cancer Control. 1996 Jan.3(1):48-50. Pubmedid: 10825276.
    • Albertini J, Cruse C, Rapaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass L, Fenske N, Reintgen D. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996 Feb.223(2):217-224. Pubmedid: 8597518. Pmcid: PMC1235100.
    • Albertini J, Lyman G, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen D. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Jama. 1996 Dec.276(22):1818-1822. Pubmedid: 8946902.
    • Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996 Aug.22(8):715-720. Pubmedid: 8780765.
    • Kallergi M, Clarke L, Qian W, Gavrielides M, Venugopal P, Berman C, Holman-Ferris S, Miller M, Clark R. Interpretation of calcifications in screen/film, digitized, and wavelet-enhanced monitor-displayed mammograms: a receiver operating characteristic study. Acad Radiol. 1996 Apr.3(4):285-293. Pubmedid: 8796676.
    • Glass L, Fenske N, Messina J, Cruse C, Rapaport D, Berman C, Puleo C, Heller R, Miliotes G, Albertini J, Reintgen D. The role of selective lymphadenectomy in the management of patients with malignant melanomoa. Dermatol Surg. 1996.21:979-983.
    • Berman C. The Role of Lymphoscintigraphy in Staging. Cancer Control. 1995 Oct.2(5):438. Pubmedid: 10862185.
    • Reintgen D, Albertini J, Berman C, Cruse C, Fenske N, Glass L, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate Nodal Staging of Malignant Melanoma. Cancer Control. 1995 Oct.2(5):405-414. Pubmedid: 10862181.
    • Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg. 1995 Nov.21(11):979-983. Pubmedid: 7582838.
    • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et a. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb.61(2):97-101. Pubmedid: 7856986 .
    • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb.61(2):97-101. Pubmedid: 7856986.
    • Reintgen D, Albertini J, Miliotes G, Berman C, Cruse C, Fenske N, Glasser S, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Cont. 1995.4:183-197. Pubmedid: noPMID.
    • Phuphanich S, Berman C, Greenberg H, Murtagh F, Prockop L. Thallium-201 SPECT index of radiation necrosis and malignant brain tumor with pathological correlation and survival. J Neuroimaging. 1995.5:68-68. Pubmedid: noPMID.
    • Wang X, Heller R, VanVoorhis N, Cruse CW, Glass F, Fenske N, Berman C, Leo-Messina J, Rappaport D, Wells K, Deconti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994 Dec.220(6):768-774. Pubmedid: 7986144. Pmcid: PMC1234479.
    • Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G. The orderly progression of melanoma nodal metastases. Ann Surg. 1994 Dec.220(6):759-767. Pubmedid: 7986143. Pmcid: PMC1234478.
    • Wells KE, Cruse CW, Daniels S, Berman C, Norman J, Reintgen DS. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994 Apr.93(4):757-761. Pubmedid: 8134434.
    • Reintgen D, Cruse C, Wells K, Berman C, Fenske N, Glass L, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rapaport D, Seigler H, Balch C. The orderly progression of melanoma nodal metastases. Ann Surg. 1994.220(6):759-767.
    • Wells K, Cruse C, Daniels S, Berman C, Norman Jr. J, Reintgen D. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994.93:757-761.
    • Wang X, Heller R, Cruse C, VanVoorhis N, Glass L, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metasases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994.220:768-774.
    • Brown HK, Hazelton TR, Parsons AK, Fiorica JV, Berman CG, Silbiger ML. PC-based multiparameter full-color display for tissue segmentation in MRI of adnexal masses. J Comput Assist Tomo. 1993 Nov.17(6):993-1005. Pubmedid: 8227595.
    • Reintgen D, Cruse CW, Schroer K, Glass F, Saba H, Puleo C, King J, Berman C, Hannon L, Cox C. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. Semin Surg Oncol. 1993 May.9(3):208-214. Pubmedid: 8516605.
    • Reintgen D, Cox C, Greenberg H, Baekey P, Nicosia S, Berman C, Clark R, Lyman G. The medical legal implications of following mammographic breast masses. Am Surg. 1993.59(2):99-105.
    • Reintgen D, Berman C, Cox C, Baekey P, Nicosia S, Greenberg H, Bush C, Lyman G, Clark R. The anatomy of missed breast cancers. Surg Oncol. 1993.2:65-75.
    • Brown H, Hazelton T, Parsons A, Fiorica J, Berman C, Silbiger M. PC-based multiparameter full-color display for tissue segmentation in MRI of adnexal masses. J Comput Assist Tomogr. 1993.17(6):993-1005.
    • Brown K, Hazelton T, Parsons A, Fiorica J, Berman C, Silbiger M. PC-based fullcolor composite display in MR imaging of adnexal masses: preliminary clinical application with quantitative image analysis and pathologic correlation. J Comput Assist Tomogr. 1993.17:995-1005.
    • Reintgen D, Cruse C, Schroer K, Glass L, Saba H, Puleo C, King J, Berman C, Hannon L, Cox C. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. Semin Surg Oncol. 1993.9:208-214.
    • Reintgen D, Cruse C, Berman C, Norman Jr. J. A redefinition of skin mapping with the use of lymphoscintigraphy: implications for elective lymph node dissection for melanoma. Melanoma Res. 1993.3:34-34.
    • Berman C, Reintgen D. Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol. 1993.9:232-238.
    • Norman Jr. J, Wells K, Kearney R, Cruse C, Berman C, Reintgen D. Identification of lymphatic basins in patients with cutaneous melanoma. Semin Surg Oncol. 1993.9:224-227.
    • Cox C, Greenberg H, Fleisher D, Clark R, Nicosia S, Berman C, Ku N, Fiorica J, Reintgen D. Natural history and clinical evaluation of the lumpectomy scar. Am Surg. 1993.59:55-59.
    • Barton DP, Berman C, Cavanagh D, Roberts WS, Hoffman MS, Fiorica JV, Finan MA. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol. 1992 Sep.46(3):341-344. Pubmedid: 1526513.
    • Berman CG, Norman J, Cruse CW, Reintgen DS, Clark RA. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992 Jan.28(1):29-32. Pubmedid: 1642403.
    • Reintgen D, Cruse CW, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass F, Alvarez L. The effectiveness of skin cancer screening and continuing medical education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992 Dec.1(6):379-384. Pubmedid: 1341274.
    • Barton D, Berman C, Cavanagh D, Roberts W, Hoffman M, Fiorica J, Finan M. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol. 1992.46:341-344.
    • Heal A, Tyson I, Greenberg H, Balducci L, Ketch R, Tenorio L, Berman C, Silbiger M. Evaluation of multiple infusions (IP) of 131-I-HMFG1 MoAb in ovarian and colorectal carcinoma patients and a nude mouse xenograft with and without IV use of unlabeled MoAb. Antibody Immunoconjugates Radiopharm. 1992.5:86-86.
    • Berman C, Norman Jr. J, Cruse C, Reintgen D, Clark R. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992.28(1):29-32.
    • Berman C, Clark R. Diagnostic imaging and cancer. Prim Care. 1992.19:677-713.
    • Reintgen D, Cruse C, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass L, Alvarez L, Brozena S, Fenske N, Fabri P. The effectiveness of skin cancer screening and continuing education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992.1:379-384.
    • Heal A, Tyson I, Greenberg H, Roberts W, Nicosia S, Berman C, Silbiger M. Pharmacokinetics, dosimetry and clinical evaluation of 131-I-HMFG1 MoAb in the therapy of colorectal and ovarian carcinoma. Antibody Immunoconjugates Radiopharm. 1992.5:1-12.
    • Norman J, Cruse CW, Espinosa C, Cox C, Berman C, Clark R, Saba H, Wells K, Reintgen D. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991 Nov.162(5):432-437. Pubmedid: 1951904.
    • Guidera KJ, Einbecker ME, Berman CG, Ogden JA, Arrington JA, Murtagh R. Magnetic resonance imaging evaluation of congenital dislocation of the hips. Clin Orthop Relat Res. 1990 Dec.(261):96-101. Pubmedid: 2245565.
    • Khera S, Kiluk J, Hasson D, Meade T, Meyers M, Dupont E, Berman C, Cox C. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 14(3):250-254. Pubmedid: 18476883.
    • Norman J, Wells K, Kearney R, Cruse CW, Berman C, Reintgen D. Identification of lymphatic drainage basins in patients with cutaneous melanoma. Semin Surg Oncol. 9(3):224-227. Pubmedid: 8516608.
    • Joseph E, Messina J, Glass FL, Cruse CW, Rapaport DP, Berman C, Greenberg H, Reintgen DS. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am. 3(6):341-345. Pubmedid: 9403046.
    • Harris E, Lafond G, Arrington J, Berman C, Brodsky N. The head and neck. In: Oncologic Imaging: a clinical perspective. The McGraw Hill Companies; 1998;79-118.
    • Dauway E, Giuliano R, Haddad F, Pendas S, Costello D, Cox C, Berman C, Ku N, Reintgen D. Lymphatic mapping in breast cancer. In: James M, ed. Hematology/Oncology Clinics of North America:brachytherapy. 13 ed. Philadelphia, PA: W.B. Saunders Company; 1999.
    • Berman C, Brodsky N, Clark R. Oncologic Imaging. 2 ed. W.B. Saunders Company; 2002.
    • Kallergi M, Berman C, Heine J, Hersh M, Hooper L, Kim J, Miller M, Galbo C, Thomas J, Clark R. Effect of default display and presentation protocol on softcopy mammography. In: Digital Mammography IWDM 2002. New York, NY: Springer-Verlag; 2003;202.
  • Patient Comments

    Overall Satisfaction

    0

    0 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey

     

    Comments

    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor